Literature DB >> 3936861

Gas chromatographic assay of triethylenethiophosphoramide in serum and urine.

B Hagen, F Walseth, R A Walstad, T Iversen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3936861     DOI： 10.1016/0378-4347(85)80150-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.

Authors:  B Hagen; G Neverdal; R A Walstad; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.

Authors:  B Hagen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Metabolism and alkylating activity of thio-TEPA in rat liver slice incubation.

Authors:  B Hagen; O Dale; G Neverdal; S Azri; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.

Authors:  B Hagen; F Walseth; R A Walstad; T Iversen; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Pharmacokinetics of thio-TEPA at two different doses.

Authors:  B Hagen; R A Walstad; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  The binding of thio-TEPA in human serum and to isolated serum protein fractions.

Authors:  B Hagen; O G Nilsen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.